Home/ Supplements/ Phosphorus/ Replace SR

Replace SR

product on market Tablet or Pill Endurance Products Company Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This product contains essential electrolytes, including sodium, potassium, magnesium, and phosphorus, which support nerve function and fluid balance. There is strong evidence for the role of these minerals in maintaining cellular homeostasis. However, the overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Replace SR
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Mineral
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

103 mg (8% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
10 mg (2% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
211 mg (38% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
Sodium
175 mg (8% DV)
Potassium
65 mg (1% DV)

Other Ingredients

Monosodium Phosphate Sodium Chloride Vegetable Wax Potassium Chloride Magnesium Citrate Stearic Acid Silica Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As an electrolyte replacement, take 1–3 tablets with a large glass of water one-half hour prior to physical activity that results in fluid loss. Dose depends on duration of activity and volume to fluid loss. Replace SR can also be taken after fluid loss to help restore electrolyte and fluid balance. Drink plenty of water according to thirst. Do not exceed the recommend dosage without consulting your physician or team doctor.

Warnings & Precautions

Consult your healthcare professional prior to use if you have or suspect a medical condition, including high blood pressure, are taking any medications, are pregnant or nursing, or are sensitive to salt.

Keep out of reach of children.

Do not use if seal is broken or missing.

Do not exceed the recommend dosage without consulting your physician or team doctor.

Formulation Notes

No sugar, starch, artificial flavors, colors, sweeteners or preservatives.

Additional Information

Store in a cool, dry place.

Formulated to release electrolytes over a 4–6 hour period.

Sustained release

Electrolyte

Buffered and balanced electrolyte replacement

11690

Metadata

Product Details

UPC / SKU7 29135 11690 4
DSLD Entry Date2018-06-25
Product TypeMineral
FormTablet or Pill
BrandEndurance Products Company
DSLD ID177697
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

Virt-Phos 250 Neutral
Virtus Pharmaceuticals · Tablet or Pill
100
Essential Minerals For Women & Men
Nature's Measure · Tablet or Pill
100
Calcium & Phosphorus With Vitamin D
Sunmark · Tablet or Pill
100
Av-Phos 250 Neutral
AvKARE · Tablet or Pill
100
Replace SR
Endurance Products Company · Tablet or Pill
100
View all Phosphorus products →
Phosphorus research Best Phosphorus All Phosphorus products More from Endurance Products Company View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.